⌘K

Login Start Free

Home/Filings/4/0001822629-25-000010

4//SEC Filing

Lalwani Nikhil 4

Accession 0001822629-25-000010

CIK 0001023024other

View on SEC.gov Company Profile

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 5:48 PM ET

Size

5.1 KB

Accession

0001822629-25-000010

Insider Transaction Report

Form 4

Period: 2025-08-12

ANI PHARMACEUTICALS INCANIP

DirectorPRESIDENT & CEO

Transactions

Sale
Common Stock
2025-08-12$85.93/sh−56,960$4,894,573→ 411,219 total

Footnotes (1)

[F1]The shares were sold in multiple trades at prices ranging from $84.40 to $87.47. The price reported above reflects the weighted average sales price.

Documents

1 file

4
wk-form4_1755208123.xmlPrimary
FORM 4

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1

filerCIK 0001822629

Filing Metadata

Form type: 4
Filed: Aug 13, 8:00 PM ET
Accepted: Aug 14, 5:48 PM ET
Size: 5.1 KB

View on SEC.gov